287 related articles for article (PubMed ID: 21225936)
1. Response of NF1-related plexiform neurofibroma to high-dose carboplatin.
Hummel T; Anyane-Yeboa A; Mo J; Towbin A; Weiss B
Pediatr Blood Cancer; 2011 Mar; 56(3):488-90. PubMed ID: 21225936
[TBL] [Abstract][Full Text] [Related]
2. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas.
Kim A; Gillespie A; Dombi E; Goodwin A; Goodspeed W; Fox E; Balis FM; Widemann BC
Neurology; 2009 Oct; 73(16):1273-9. PubMed ID: 19841379
[TBL] [Abstract][Full Text] [Related]
4. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
[TBL] [Abstract][Full Text] [Related]
5. Growth type of plexiform neurofibromas in NF1 determined on magnetic resonance images.
Friedrich RE; Korf B; Fünsterer C; Mautner VF
Anticancer Res; 2003; 23(2A):949-52. PubMed ID: 12820328
[TBL] [Abstract][Full Text] [Related]
6. Giant plexiform neurofibroma in a patient with neurofibromatosis type I.
Rallis E; Ragiadakou D
Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985
[TBL] [Abstract][Full Text] [Related]
7. [Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1].
Benchikhi H; Zeller J; Wolkenstein P; Wechsler J; Vidaud D; Revuz J
Ann Dermatol Venereol; 1995; 122(9):601-3. PubMed ID: 8745684
[TBL] [Abstract][Full Text] [Related]
8. Dysplasia of the orbit and adjacent bone associated with plexiform neurofibroma and ocular disease in 42 NF-1 patients.
Friedrich RE; Stelljes C; Hagel C; Giese M; Scheuer HA
Anticancer Res; 2010 May; 30(5):1751-64. PubMed ID: 20592374
[TBL] [Abstract][Full Text] [Related]
9. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Burgueno M; Martin-Perez M; Palencia R; Garcia-Segura JM; Valero C
Rev Neurol; 2006 Sep 16-30; 43(6):346-52. PubMed ID: 16981165
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of plexiform neurofibroma in neurofibromatosis type 1 in 18 family members of 3 generations: ultrasonography and magnetic resonance imaging a diagnostic supplement.
Sehgal VN; Sharma S; Oberai R
Int J Dermatol; 2009 Mar; 48(3):275-9. PubMed ID: 19261016
[TBL] [Abstract][Full Text] [Related]
11. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
12. Plexiform neurofibroma of uterus: a rare manifestation of neurofibromatosis 1.
Shahzad R; Younas F
J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S22-3. PubMed ID: 24717994
[TBL] [Abstract][Full Text] [Related]
13. Plexiform neurofibromas in NF1: toward biologic-based therapy.
Packer RJ; Gutmann DH; Rubenstein A; Viskochil D; Zimmerman RA; Vezina G; Small J; Korf B
Neurology; 2002 May; 58(10):1461-70. PubMed ID: 12041525
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α for unresectable progressive and symptomatic plexiform neurofibromas.
Kebudi R; Cakir FB; Gorgun O
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e115-7. PubMed ID: 23042022
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib for plexiform neurofibromas in neurofibromatosis type 1: a single-institution experience.
Espírito Santo V; Passos J; Nzwalo H; Carvalho I; Santos F; Martins C; Salgado L; Silva CE; Vinhais S; Vilares M; Salgado D; Nunes S
J Neurooncol; 2020 Apr; 147(2):459-463. PubMed ID: 32108293
[TBL] [Abstract][Full Text] [Related]
16. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ; Shih CS; Rhodes SD; Armstrong AE; Wolters PL; Dombi E; Zhang C; Angus SP; Johnson GL; Packer RJ; Allen JC; Ullrich NJ; Goldman S; Gutmann DH; Plotkin SR; Rosser T; Robertson KA; Widemann BC; Smith AE; Bessler WK; He Y; Park SJ; Mund JA; Jiang L; Bijangi-Vishehsaraei K; Robinson CT; Cutter GR; Korf BR; ; Blakeley JO; Clapp DW
Nat Med; 2021 Jan; 27(1):165-173. PubMed ID: 33442015
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
[TBL] [Abstract][Full Text] [Related]
18. Resection of plexiform neurofibromas in children with neurofibromatosis type 1.
Canavese F; Krajbich JI
J Pediatr Orthop; 2011; 31(3):303-11. PubMed ID: 21415691
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Widemann BC; Babovic-Vuksanovic D; Dombi E; Wolters PL; Goldman S; Martin S; Goodwin A; Goodspeed W; Kieran MW; Cohen B; Blaney SM; King A; Solomon J; Patronas N; Balis FM; Fox E; Steinberg SM; Packer RJ
Pediatr Blood Cancer; 2014 Sep; 61(9):1598-602. PubMed ID: 24753394
[TBL] [Abstract][Full Text] [Related]
20. Single-stage total endoscopic resection of a plexiform neurofibroma of the maxillary sinus in a child with type 1 neurofibromatosis.
Hachem RN; Bared A; Zeitouni J; Younis RT
Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):426-9. PubMed ID: 20074816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
